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ABSTRACT 
 
 
SHENEE’ K. LAURENCE  
ASSOCIATION BETWEEN PREOPERATIVE PULMONARY REHABILITATION AND 
POSTOPERATIVE HOSPITAL OUTCOMES 
(Under the direction of SHANTA R. DUBE) 
 
INTRODUCTION: Preoperative pulmonary rehabilitation (PPR) is an emerging therapy for 
transplant candidates who are awaiting surgery. Research indicates that PPR training has benefits 
for improving exercise tolerance, but little researcher exists on the association between PPR on 
post-transplant hospital outcomes. 
METHODS: The study was a non-probability cross-sectional analysis performed on data for 
post-transplant recipients who received either a single or bilateral lung transplant from February 
8, 2007 to July 8, 2014. The study sample consisted of 207 transplant recipients. Analyses of the 
associations between independent variables: preoperative pulmonary rehabilitation and six-
minute walk distance (6MWD) and covariates were performed by logistic regression analysis to 
examine the following outcomes: length of stay, hospital readmissions in the first 90 days post- 
transplant, and the number of hospital readmissions in the first 90 days. 
RESULTS: Transplant recipients who participated in preoperative pulmonary rehabilitation had 
1.77 times greater odds of being readmitted in the first 90 days post-transplant compared to 
recipients who did not participated in preoperative pulmonary rehabilitation. Transplant 
recipients whose 6MWD was greater than 207 meters and who participated in preoperative 
pulmonary rehabilitation had 4.99 times greater odds of length of staying 12 days or less post- 
transplant surgery compared to transplant recipients whose walk distance was less than 207 
meters and who did not participate in preoperative pulmonary rehabilitation. 
CONCLUSION: Pulmonary rehabilitation is an important part of the lung transplant. The 
results of this study indicate the importance of preoperative lung transplant on post-transplant 
outcomes for transplant recipients. 
INDEX WORDS: preoperative pulmonary rehabilitation, six-minute walk distance, length of 
stay, lung transplant 
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CHAPTER I.  
INTRODUCTION 
Based on the most up to date data published in February of this year by the Organ 
Procurement and Transplant Network website there are currently 1,644 lung transplant 
candidates on the national waiting list. In the state of Georgia, there are 28 lung transplant 
candidates on the waiting list. The average wait time on the national wait list for a lung 
transplant is a year to two years. In Georgia, the average wait time is six months to less than a 
year.  This extended time spent on the waiting list for a lung transplant could be detrimental to a 
waitlisted candidate for two reason.  The transplant’s disease progression could deteriorate to the 
point where the candidate becomes too ill for transplant surgery.  The other reason is due to their 
exercise intolerance and their inability to participate in daily exercise; they become too 
deconditioned to have lung transplant surgery.  These reasons explain the important role 
preoperative pulmonary rehabilitation plays for waitlisted transplant candidates. Pulmonary 
rehabilitation maintains endurance, strength, and overall good health, which is why participation 
in preoperative pulmonary rehabilitation is an important part of the pre-transplant process. There 
is evidence that pulmonary rehabilitation can stabilize, and potentially reverse many systemic 
manifestations of the disease processes. Pulmonary rehabilitation helps with advanced lung 
disease management and improvements in quality of life (Yusen et al., 2010). 
Since the middle of the 20th century, pulmonary rehabilitation and its components have 
been used by clinicians. During this time, the use of pulmonary rehabilitation was based on 
expert opinion from trial and error. The first randomized clinical trial of pulmonary rehabilitation 
occurred in 1991, with a small group of 19 recipients diagnosed with chronic obstructive 
pulmonary disease (COPD). The aim of the study was to see if recipients experienced marked 
improvement with higher or lower levels of exercise training which using a cycle ergometer. 
Results of the study showed higher levels of training correlated to better outcomes. In 1994, the 
first study related the effects of pulmonary rehabilitation and dyspnea demonstrated that 
pulmonary rehabilitation can decrease ventilatory demand and reduction in post- exercise 
dyspnea. In 1996, the first large randomized control trial of 119 recipients diagnosed with 
COPD, received treatment at a comprehensive outpatient pulmonary (which included education 
and exercise training). The results of the program showed improvements, but a decline in the 
improvements after 18 months. Over the next 11 years, pulmonary rehabilitation would reach 
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several milestones. In 2007, the American College of Chest Physicians (ACCP) and the 
American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) documented 
very strong evidence supporting the effectiveness of upper and lower extremities in exercise 
training. They also recorded improvements in dyspnea and quality of life. The ACCP and 
AACVPR summarized the current evidence-based guidelines for pulmonary rehabilitation.  In 
2008, pulmonary rehabilitation became the most effective therapy in increasing exercise capacity 
of COPD recipients and was added to the current treatment algorithm for COPD by the Global 
Initiative for Obstructive Lung Disease (GOLD). Pulmonary rehabilitation became a covered 
benefit for selected aspects of COPD under the Centers for Medicare and Medicaid (CMS) in 
January 2010 (Nici & Zuwallack, 2011). 
Statement of the Problem 
  Due to the exercise intolerance caused by to physiology changes of end-stage lung 
disease, many recipients are often much more deconditioned than recipients without end-stage 
lung diseases prior to lung transplantation surgery. A person’s pre-transplant physical activity 
status is contributory to their post-transplant physical function. Limited physical activity prior to 
a major surgery such as lung transplantation, increases an individual’s morbidity and mortality 
during their hospital stay.  
Purpose of the Study 
There are numerous studies on the benefits of pulmonary rehabilitation after lung 
transplantation, but few studies exist on the benefits pre-transplant.  This retrospective study 
determines if there is an association between participation in preoperative pulmonary 
rehabilitation and hospital outcomes. The next chapter will the review the current literature on 
preoperative pulmonary rehabilitation in non-restrictive and restrictive lung diseases and the 
benefits of preoperative pulmonary rehabilitation for waitlisted lung transplant candidates.  
Research Questions: 
 The researcher sets out to understand the impact of preoperative pulmonary rehabilitation 
on the number of hospital readmissions in the first 90 days post-transplant. Specifically, the 
research will determine the relationship of preoperative pulmonary rehabilitation and 6MWD on 
hospital outcomes. 
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Research Question 1: Do lung transplant recipients who engaged in preoperative pulmonary 
rehabilitation differ on post-operative hospital readmissions compared to those who did not 
engage in preoperative pulmonary rehabilitation? 
H01: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have 
an equal odds of being readmitted post 90 days compared to lung transplant recipients who did 
not engage in preoperative pulmonary rehabilitation. 
H02: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have 
an equal odds of having < 2 readmissions when compared to lung transplant recipients who did 
not engage in preoperative pulmonary rehabilitation. 
 
Research Question 2: Do lung transplant recipients who engaged in 6MWD differ on hospital 
length of stay post-surgery compared to those who did not engage in a 6MWD? 
H01: Lung transplant recipients who engaged in 6MWD will have an equal odds of having ≤ 12 
day stay compared to lung transplant recipients who did not engage in 6MWD.  
 
Exploratory Research Question 3: Do lung transplant recipients who did not engage in both 
preoperative pulmonary rehabilitation and 6MWD differ on hospital admissions from those who 
engaged in at least one or both of the preoperative behaviors?  
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CHAPTER II 
LITERATURE REVIEW 
 A literature review was conducted to examine the body of literature that was relevant to 
the research question: Does preoperative pulmonary rehabilitation among lung transplant 
recipients result in reduced hospital readmissions in the first 90 days after lung transplant 
surgery? Prior to selecting the research articles, the researcher reviewed the definition of 
pulmonary rehabilitation to ensure the literature review captured the broad definitions of 
pulmonary rehabilitation and how preoperative pulmonary rehabilitation is beneficial. 
 A literature search was performed using the following databases: PubMed, PubFacts, 
Google, and ERIC. The following search terms were used to conduct literature review: definition 
of pulmonary rehabilitation, home-based pulmonary rehabilitation, outpatient pulmonary 
rehabilitation, preoperative rehabilitation and transplant candidates, benefits of pulmonary 
rehabilitation and the following diseases: COPD, Cystic Fibrosis, Idiopathic Pulmonary 
Fibrosis, Pulmonary Hypertension, Bronchiectasis, Pulmonary Fibrosis, and Sarcoidosis, 
exercise testing determines survival, and 6 MWD prognostic factor and survival in transplant 
recipients. This literature review’s organized in the following thematic format (a) definitions of 
pulmonary rehabilitation, (b) pulmonary rehabilitation settings, (c) general benefits of 
preoperative pulmonary rehabilitation for COPD and non-COPD diseases; (d) benefits of 
preoperative pulmonary prior to lung transplant surgery; and (e) 6MWD as determinants of 
survival for transplant candidates. 
Definitions of Pulmonary Rehabilitation  
  In 2006, the American Thoracic Society (ATS) and European Respiratory Society (ERS) 
adopted a new definition of pulmonary rehabilitation. They defined pulmonary rehabilitation as: 
“Pulmonary rehabilitation is an evidence-based, multidisciplinary and comprehensive 
intervention for recipients with chronic lung disorders who are symptomatic and have some 
disability. Pulmonary rehabilitation is aimed to decrease symptoms, optimize functional state, 
increase participation, and reduce health-care costs through stabilizing or reversing systemic 
manifestations of the disease” (Nici et al., 2006). The ATS and ERS’ broader definition of 
pulmonary rehabilitation is a strategic patient-centered intervention plan where the goal is the 
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lifelong management of patient’s chronic respiratory symptoms. The patient-centered 
intervention plan should be a dynamic multidisciplinary collaboration among the patient, family, 
and healthcare workers. The aim of the intervention program is to address both the primary and 
secondary deteriorations of the recipients’ disease process. 
 Pulmonary rehabilitation programs, as described by Troosters, Grosselink, Janssens, and 
Decramer (2010), are exercise training intervention programs with a multidisciplinary approach. 
A simpler is definition is an exercise program used to reverse the systemic skeletal muscle 
dysfunction in respiratory diseases. The aim of the pulmonary rehabilitation program should be 
to increase ventilatory efficiency, reduced dyspnea, and increased exercise capacity and to be 
performed at a minimum of 3 times per a week for at least eight weeks. 
 Nici & Zuwallack, (2011) define pulmonary rehabilitation as comprehensive 
interventions for recipients with chronic advanced respiratory disease. These are recipients who 
are symptomatic and have experience decreased daily life activities.  Pulmonary rehabilitation 
interventions would reduce symptoms, improve functional status, increase participation and 
reduce healthcare costs.  
 With the advances in the understanding of the science and processes of pulmonary 
rehabilitation, in 2013 the ATS and ERS decided to update the definition of pulmonary 
rehabilitation. The first definition of pulmonary rehabilitation created seven years prior was an 
evidence-based, multidisciplinary approach for treating advanced chronic respiratory diseases 
with the focus on stabilizing the disease reversing and systemic manifestations. The ATS and 
ERS gained a more comprehensive understanding of the parts of pulmonary rehabilitation 
combined with years of clinical experience and expert opinion.  With this newfound 
understanding, the ATS and ERS revised the definition of pulmonary rehabilitation 
interdisciplinary intervention for recipients with any respiratory disease that included focus on 
behavior modifications. The ATS and ERS’ new adopted definition stated: “Pulmonary 
rehabilitation is a comprehensive intervention based on a thorough patient assessment followed 
by patient-tailored therapies, which include, but are not limited to, exercise training, education, 
and behavior change, designed to improve the physical and psychological condition of people 
with chronic respiratory disease and to promote the long-term adherence to health-enhancing 
behaviors.” (Martijn et al., 2013). 
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 The new ATS and ETS’ definition of pulmonary rehabilitation is a more individualized 
patient-centered intervention.  The main components of the pulmonary program: exercise 
training, self-management education, and behavioral modification remain the same as the 
pulmonary rehabilitation program defined in 2006. The format of the pulmonary rehabilitation 
programs may vary. Similarly, the indication for pulmonary rehabilitation no longer is restrained 
to recipients suffering from COPD but to recipients who illustrate symptoms of shortness of 
breath at a regular pace on level ground while on optimum therapy. Pulmonary rehabilitation 
should be individualized including age specific, cultural sensitive, and both patient and family 
involvement (Al Moamary, Aloniny, & Al-Hajjaj, 2014). The team involved should include 
interdisciplinary team members (i.e. physicians, respiratory therapists, nurse, social workers, or 
occupational therapists). The focus of the interventions should be unique to the needs of the 
recipients, based on initial, current and ongoing assessments. The interventions should be in 
direct correlation with the patient’s disease severity, complexity, and comorbidities (Martijn, 
2013).  
The use of the term ‘intervention’ for pulmonary rehabilitation has the implied meaning 
that pulmonary rehabilitation is to be prescribed as a treatment plan. Troosters, Gosselink, 
Janssens & Decramer (2010), state there are reported extensive benefits of pulmonary 
rehabilitation in stable lung disease recipients. However in recipients with milder disease there is 
limited efficacy of pulmonary rehabilitation due to limited substantial evidence. This is evident 
in a trial conducted in recipients with a forced expiratory volume less than 60% in one second 
only showed modest improvements after pulmonary rehabilitation.  
Contrarily, Martijn et al. shows with more clinically expert based data pulmonary 
rehabilitation can be integrated throughout the clinical course of a patient’s disease; therefore it 
can be initiated at any stage of the disease. Pulmonary rehabilitation can be recommended during 
periods of clinical stability or directly after an exacerbation. The goal of pulmonary rehabilitation 
is to minimize symptom burden and maximize exercise performance. While promoting 
autonomy pulmonary rehabilitation, increasing participation in activities of daily living, quality 
of life, and enhancing long-term health changing behavior (2014).  
Complementary to this, Troosters, Hornikx, Demeyer, Camillo, Janssens (2014), agree 
there are recipients who should be prescribed pulmonary rehabilitation without hesitation. 
Recipients who have recently been admitted to the hospital with acute COPD exacerbations and 
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recipients with severe dyspnea in whom all pharmacologic options have been exhausted. The 
potential beneficial gains of pulmonary rehabilitation for these two group of recipients is 
essential for their lung function. 
Pulmonary Rehabilitation: Hospital-based and Home-based Pulmonary Rehabilitation 
 Traditionally, pulmonary rehabilitation programs were performed in hospital-based 
facilities. In the early 1990s, home-based pulmonary rehabilitation programs became popular 
options for recipients. The current trend is hospital-based pulmonary rehabilitation programs. 
Inpatient pulmonary programs are thought to be the optimal pulmonary rehabilitations setting for 
lung transplant recipients to receive pulmonary rehabilitation in terms of setting, supervision, 
complexity, and duration. As the burden of end-stage lung disease continues increases and rising 
healthcare costs perhaps a way to increase the number of transplant recipients in pulmonary 
rehabilitations is to approve home-based programs. There naturally will be challenges in the 
funding and management of home based programs, but the pros of home-based pulmonary 
programs far outweigh the cons. 
 A group of researchers have completed studies analyzing the efficacy of home-based 
pulmonary rehabilitation programs compared to hospital-based programs (Mathis et al., 2008; 
Mendes de Oliveira et al., 2008).  
 Malthis et al. (2008) completed a study of 252 recipients who after a 4-week education 
program took part in home-based rehabilitation or hospital-based rehabilitation for eight weeks. 
The transplant recipients were followed for 40-weeks to complete a one year study. The results 
of the study showed improved cycling endurance time at three months, both groups associated 
with statistically and clinically significant improvement in health status. Overall at three months 
and one year both rehabilitation strategies, home-based and hospital-based, had similar efficacy 
in 6MWD, endurance time, and improvements in dyspnea. The clinical trial provides evidence 
that using self-monitored home-based pulmonary rehabilitation may be a viable option for 
recipients.    
 The results of the randomized controlled prospective study by Merdes de Oliveira et al. 
revealed the clinical benefits (6MWD) achieved in the clinical setting were not significantly 
greater than those achieved in the self-monitored home modality. The results of this study also 
revealed another positive aspect the retention rate of participation. The dropout rate was notably 
less in the at home group than in the hospital-based group. The researchers feel the positive 
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results of this study demonstrate home-based pulmonary rehabilitation is logistically easier and 
will have greater patient adherence due to non-necessity of transportation to specialized clinics 
(2010). 
 The benefits of home-based pulmonary rehabilitation were shown to extend to recipients 
with restrictive lung diseases in a study conducted by Kapaya, Takahaskhi, Sugawara, Kasai, 
Kiyokawa, and Shioya (2009). The study was a multidisciplinary home-based program. The 
home-based program included: exercise training with upper and lower limb exercises, respiratory 
muscles stretching calisthenics, level walking for at least 15 minutes inspiratory and expiratory 
muscles forces and a 45 minute education class. The results of the study showed that PR for 
restrictive lung diseases has the same effects as recipients with COPD if the severity of the 
disease was similar. The restrictive lung disease group had increases in six-minute walk distance, 
exercise intolerance, and quality of life. 
 Conversely, Elliott et al., (2011) tested the effect of home-based program on the recovery 
of lung transplant recipients.  The study was an individualized eight week home-based physical 
rehabilitation program. The program was conducted through a multi-center randomized 
controlled trial to assess the physical function of pulmonary rehabilitation on recipients who 
survived a critical illness. The results of the study revealed the home-based rehabilitation both 
groups did have improvements in physical endurance. The researchers contribute the lack of a 
significant improvement due to lack of compliance since sessions were unsupervised, and 
training intensity was not adequate.  
 For most of the comparison research on hospital-based versus home-based pulmonary 
rehabilitation; there is evidence of results showing the efficacy of home-based programs if 
recipients are well selected and supervision is provided.  
Respiratory Illnesses Potentially Requiring Lung Transplantation  
  Chronic obstructive pulmonary disease (COPD) is a type of lung disease where 
airflow is chronically obstructed. This obstructed airflow interferes and prohibits normal 
breathing; COPD is not fully reversible and is the third leading cause of death in United States. 
The prevalence of COPD among adults in the United States varies considerably by state and 
region. The prevalence of COPD is less than 4% in Washington and Minnesota compared to 
greater than 9% in Alabama and Kentucky. The area in the United States with the highest COPD 
prevalence cluster is along the Ohio and lower Mississippi Rivers. There has been declined in the 
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number of deaths related to COPD in men (10.6 per 100,000 between 1999 and 2010). 
Unfortunately, there has been no significant change in death rate had occurred in women. The 
prevalence rates for women were 35.3 per 100,000 in 1999 and 36.4 per 100,000 in 2010 
(“COPD among Georgia Adults”, n.d.). 
Individuals in the state of Georgia with COPD are more likely to be Caucasian, age 55 
years or older, female, unable to work and have less than a high school diploma. A current 
household income of less than $25,000 are divorced, separated or widowed and have a history of 
smoking or asthma (http://www.cdc.gov/copd/data.htm). The demographics of Georgians with 
COPD are summarized in the table below. 
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Interstitial lung diseases (ILD) this is a broad term that describes a collection of over 200 
chronic lung diseases.  These respiratory diseases are grouped together based on how the affect 
Table 1.1 Demographics of Georgia Adults with 
COPD (data obtained from 2011 BRFSS) 
 
 
Characteristics Percentage % 
Age Group (Years)  
18-44 3.8 
45-54 7.4 
55-64 11.5 
65-74 13.7 
>75 12.4 
Race/Ethnicity  
White 8.3 
Black 5.4 
Hispanic 0 
Other 7.8 
Gender  
Male 5.6 
Female 8.2 
Employment Status  
Employed 2.7 
Unemployed 8.5 
Homemaker/Student 4 
Retired 11.8 
Unable to work 29 
Education   
Less than high school diploma or GED 14.7 
High school diploma or GED 7.2 
At least some College 4.3 
Income  
<$25,000 12.3 
$25,000-$49,999 5.7 
$50,000-$74,999 3.6 
>$75,000 2.1 
Marital Status  
Married 6 
Divorced/Widowed/Separated 13.8 
Never Married 3.6 
Member of Unmarried Couple 0 
Smoking Status  
Current Smoker 14.2 
Former Smoker 9.2 
Never Smoked 3.4 
Ever had Asthma  
Yes 25.3 
No 4 
  
the respiratory system-lack of these diseases affect the tissue space around alveoli (air sacs), the 
interstitium, and may also affect other compartments of the lungs, the alveoli, the
bronchi, blood vessels and pleura. 
breath and cough, b) specific chest radiographic abnormalities, 
pulmonary function tests, d) characteristics microscopic 
ILD was considered a rare disease, but unfortunately the prevalence of ILD has increased. In the 
United States 80.9 per 100, 000 men and 67.2 per 100,000 women suffer from ILD, with 31.5 
new cases for men and 26.1 new 
commonly diagnosed ILD diseases included pulmonary fibrosis, occupational and environmental 
associated disease, and sarcoidosis. IPF affects adults, most often occurs between ages of 40 and 
70, but may occur earlier in these with a history of IPF. IPF is more common and deadly in 
Caucasian than in African Americans
 Cystic fibrosis is the second most common life shortening hereditary
United States after sickle cell anemia. 
wheezing or shortness of breath, persistent cough and excessive mucus, frequent lung infections 
(pneumonia and bronchitis), frequent sinus infections, nasa
growth, fouls-smelling greasy stools, and broadening of fingertips and toes. 
there are approximately 30,000 Americans diagnosed with CF and 1,000 new cases are 
diagnosed yearly. Cystic fibrosis equally af
every race, Caucasians of Northern European descent are more often diagnosed with cystic 
fibrosis, with every 1 in 2500 Caucasian births being affected. The median age survival for a 
person with cystic fibrosis without a lung transplant is 37.4 years; the age adjusted death rate is 
higher for Caucasians (0.22 per 100,000) than other racial and ethnic groups
n.d).   
 
  
 
 
Table 1 Cystic Fibrosis Age Adjusted Death Rates
    
 
11 
There are four main manifestations of ILD:  a) shortness of 
c) decrease in lung volume on 
patterns of inflammation and fibrosis. 
cases per 100,000 for women diagnosed every year. The most 
 (“Interstitial lung disease”, 2012).  
 disease
 Symptoms of cystic fibrosis are salty tasting skin, 
l polyps, poor weight gain and 
In the United States 
fects males and females, while it does occur in
 (“Cystic Fibrosis, 
 
 
 trachea, 
 in the 
 nearly 
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Bronchiectasis (non-cystic fibrosis) is a chronic condition characterized by irreversible 
widening of the medium sized airways with inflammation, chronic bacterial infection and 
destruction of the bronchial walls. The characteristic features are abnormally dilated thick-walled 
bronchi that are inflamed and chronically infected by bacteria. The symptoms of non-CF 
bronchiectasis vary from person to person; some recipients have no symptoms at all, some 
recipients have symptoms only during exacerbations, and other recipients have experience 
symptoms daily. The clinical manifestations of non-CF bronchiectasis are persistent cough with 
daily micropurulent sputum production (lasting months to years), recurrent pulmonary infections 
resulting in airway damage which may produce streaked sputum and hemoptysis, dyspnea, 
wheezing, pleuritic chest pain, and adventitious breath sounds (crackles, wheezing, or rhonchi) 
[Neves, Guerra, Ponce, Miranda, and Vouga, 2011]. 
 In analysis of US health plan claims for over 46 healthcare plans in 2009, Dwibedi, Joish, 
Spilsbury-Cantalupo, Operschall and Luong (2012), found  the prevalence of non-CF 
bronchiectasis increased with increasing age; prevalence was lowest among individuals younger 
than 18 years of age (4.48 per 100,00) and highest among individuals 75 years of age and older 
(378.74 per 100,000). In terms of gender differences non-CF bronchiectasis was more prevalent 
among women. Dwibedhi et al. also noted regional variations across nine census regions with 
Middle Atlantic Regions having the highest prevalence at 57.29 per 100,000 and west North 
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Central regions having the lowest prevalence of non-CF bronchiectasis at 28.60 per 100,000 
(2012). 
 In another study of US Medicare data, the 8 year period of prevalence of non-CF 
prevalence increased by 8.7% per year of life. The report also suggested in terms of ethnicity 
there is a higher prevalence among Asians compared to African Americans and European-
Americans (“Bronchiectasis”, 2012). 
Pulmonary hypertension is a respiratory illness which there is high blood pressure in the 
lung arteries; the arteries narrow and decreases blood flow. Over time the arteries stiffen and 
become blocked – this narrowing of the pulmonary arteries over times causes stress on the heart 
and leads to the enlarge heart and heat failure. The symptoms of pulmonary hypertension during 
the initial stage of the disease are common to many other medical conditions: difficulty 
breathing, fatigue, shortness of breath. As the disease progresses the symptoms become more 
severe: dizziness, chest pain, ankle swelling, and palpitations.  
Due to lack of specific ICD-9 codes for the conditions of pulmonary hypertension and 
risk of misdiagnosis; the exact prevalence of PH is largely unknown. Kirson et al analyzed 
private insurance claims and Medicare database claims from 1999 to 2007. The results of the 
data analysis revealed the prevalence rates of PH increases with age and are higher among 
women. The data analysis also showed the estimated US prevalence of PH is higher than existing 
estimates (Kirson, Birnbaum,Ivanova, Waldmen, Joish, and Williamson, 2011).  
As the above diseases progress and become more debilitating, lung transplantation is the 
therapeutic measure for recipients with end-stage lung diseases who have exhausted all other 
available treatments without improvements. In order to become a transplant recipients there are 
certain criteria candidates have to meet prior to transplantation. While the requirements vary 
from transplant center these are the generally agreed upon criteria: 
• End-stage lung disease 
• Has exhausted other available therapies without success 
•  No other compounding comorbidities involving heart, kidney, liver 
• No  HIV, untreated Hepatitis, cancers 
• Not currently using/abusing alcohol, smoking, drug abuse 
• Acceptable BMI (usually above the range of malnourished and below the range of 
obese) 
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• Age 
• Acceptable psychological profile  
• Adequate social support 
• Financial able to pay for expenses post-transplant 
• Able to comply with post-transplant regimen.   
• Acceptable results from extensive medical tests which evaluate their overall 
health status and suitability for transplant surgery 
Once a person is accepted as by a transplant center, they are added to recipient waiting 
list and assigned a lung allocation score (LAS). The LAS takes into account various measures of 
the patient’s health. The LAS system allocates donated lungs according to the immediacy of 
need rather than how long a patient has been on the transplant list.  
The following table is information from UNOS database illustrating the number of lung 
transplants completed from January 1, 1998 to November 30, 2014. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.2 Number of Lung Transplants performed from January 1, 1999 to November 30, 
2014 
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on Adults Living in the United States 
 
Physiology of Exercise Intolerance in Obstructive and Restrictive Respiratory Diseases  
There is a direct association between obstructive respiratory diseases, such as COPD and 
ventilatory constraints, abnormal pulmonary gas exchange, peripheral muscle dysfunction, 
cardiac dysfunction, and limitations due to lower limb and respiratory muscle dysfunction. Each 
of these processes alone or a combination of can lead to exercise intolerance. 
 Ventilatory limitations. Spruitt et al. describe the ventilatory limitations 
(constraints) requirements experienced by recipients diagnosed with COPD are due to increase 
work of breathing, increased dead space ventilation, impaired gas exchange and increased 
ventilatory demand as a consequence of deconditioning and peripheral muscle dysfunction. The 
 COPD Cystic 
Fibrosis 
Non-CF Bronchiectasis Pulmonary 
Hypertension 
 
ILD Total 
Caucasian       
Male 3941 1834 173 232 4516 10696 
Female 4180 1612 202 489 1656 8139 
Caucasian Total      18835 
African  American       
Male 219 17 23 11 258 528 
Female 240 21 9 56 266 592 
African American Total       
1120 
Hispanic       
Male 63 47 19 19 391 539 
Female 43 45 35 40 217 380 
Hispanic Total      919 
Unknown       
Male 0 1 0 0 1 2 
Female 1 0 1 0 1 3 
Unknown Total      5 
Asian       
Male 14 1 9 3 98 125 
Female 8 0 9 15 42 74 
Asian Total      199 
American 
Indian/Alaskan Native 
      
Male 5 3 2 7 14 31 
Female 10 2 1 4 14 31 
American 
Indian/Alaskan Native 
Total 
      
 
62 
Pacific Islander       
Male 0 0 1 2 6 9 
Female 1 0 1 2 2 6 
Pacific Islander Total       
15 
Multi-Racial       
Male 4 0 2 1 7 14 
Female 12 2 1 1 9 25 
Multi-Racial Total      39 
Total 8741 (31.6 
%) 
3585 
(13.0%) 
488 
(1.8%) 
875 
(3.2%) 
7498 
(27.1%) 
21187 
(76.7%) 
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increase in demand causes a limit in the maximum ventilation during exercise resulting in two 
respiratory symptoms of COPD: expiratory airflow obstruction and hyperinflation. Expiratory 
airflow obstruction and hyperinflation lead to further increased work of breathing, increased load 
and mechanical constraints on the respiratory muscles-this leads to an increasing intensified 
sense of dyspnea (2013).  
 Gas exchange limitation. Pulmonary ventilation increases as a direct result of hypoxia. 
Hypoxia causes an increase in pulmonary ventilation by changing peripheral chemoreceptor 
outputs and indirectly stimulating lactic acid production. This process causes a set of change 
reactions: lactic academia occurs as a result of anaerobic metabolism by the muscles during 
higher intensity exercise; leads to failure of the muscle tasks and thus increases pulmonary 
ventilation. Lactic acid buffering results in an increase in carbon dioxide production and acidosis 
stimulating the carotid bodies (Martijn et al., 2013). 
 Cardiac limitations. Chronic respiratory disease also affect the cardiovascular system in 
numerous ways: the main way is an increase in the right ventricular afterload. The consequences 
of overloaded right ventricular  may lead to right ventricular hypertrophy and failure which can 
cause compromise left ventricular filling by producing septal shifts, which further decreases the 
hearts ability to meet exercise demands leading to tachyarrhythmias or right atrial pressure 
(Martijn, 2012).  
 Limitations due to lower limb and respiratory muscle dysfunction. The peripheral 
muscle dysfunction experienced in recipients with COPD is caused by single or multifactorial 
causes: inactivity induced deconditioning, systemic inflammation, oxidative stress, smoking, 
blood gases disturbances, nutritional imbalances, abnormally low hormone levels, aging, or 
prolonged corticosteroid use. Other factors leading to skeletal muscle dysfunction is the 
increased ventilatory requirements recipients with COPD experience with any given exercise 
work rate, which causes an increasing burden on the respiratory muscles (Martijn et al., 2012). 
 In order to adapt to chronic overload the diaphragm of individuals with COPD have 
greater resistance to fatigue; the inspiratory muscles are capable of generating more pressure 
than non COPD individuals. While this resistance to fatigue may be seen as an advantage it 
actual causes recipients with COPD to experience static and dynamic hyperinflation, which 
places their muscles at a mechanical disadvantage. Even with the adaptation in their diaphragm 
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individuals with COPD still experience both inspiratory muscle strength and inspiratory muscle 
endurance weakness, which causes reduced exercise performance (Martijn, 2013). 
Research has shown the physiology effects of exercise intolerance of restrictive lung 
disease are similar to the symptoms of obstructive respiratory disorders. These restrictive lung 
conditions are, but not limited to, interstitial lung disease, non-cystic fibrosis bronchiectasis, and 
pulmonary arterial hypertension. 
 Exercise intolerance is a key feature in restrictive lung disorders and characteristic 
symptoms are dyspnea on exertion or hypoxemia.  Exercise intolerance in restrictive respiratory 
diseases are caused by many of the same mechanisms as obstructive respiratory diseases: 
impaired gas exchange, circulatory limitations, altered respiratory mechanisms, abnormalities in 
muscle oxygen extraction and utilization, abnormal breathing patterns, and dynamic 
hypoinflation during exertion (Markovitz and Cooper, 2010). 
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Benefits of Pulmonary Rehabilitation on Exercise Intolerance and Prior To Lung Transplant Surgery  
Literature Review of the Benefits of PR for Obstructive Respiratory Diseases 
Author/title Study Aim Sample Results Implications for practice, research, theory 
Pulmonary 
rehabilitation improves 
cardiovascular response 
to exercise in COPD. 
 
Ramponi et al. 
 
 
 
 
 27 recipients diagnosed 
with COPD who 
participated in 9 week 
pulmonary rehabilitation 
program 
transplant recipients experienced 
enhanced ventilatory capacity while 
exercising which lead to an enhancement 
in their breathing patterns. This 
enhancement in their breathing pattern 
was associated with reduced with dynamic 
hyperinflation and also improved exercise 
intolerance 
 
 
Benefits of pulmonary 
rehabilitation in 
patients with COPD 
and normal exercise 
capacity. 
 
Lan et al. 
 
 
The effects of PR 
in patients with 
normal exercise 
capacity on health-
related quality of 
life and exercise 
capacity. 
Twenty-six subjects with 
COPD and normal exercise 
capacity were studied. All 
subjects participated in 12-
week, 2 sessions per week, 
hospital-based, out-patient 
PR. Baseline and post-PR 
status were evaluated by 
spirometry, the St George's 
Respiratory Questionnaire, 
cardiopulmonary exercise 
test, respiratory muscle 
strength, and dyspnea 
scores. 
revealed two positive effects of 
pulmonary rehabilitation on ventilatory 
limitations: improved the exercise 
capacity and level of exertional dyspnea. 
The scores of dyspnea at the end of the 
exercise pre-pulmonary rehabilitation was 
5.7. The scores of dyspnea decreased by 
0.9 points post-pulmonary rehabilitation. 
The scores of the level of exertional 
dyspnea post pulmonary rehabilitation 
were nearly that of healthy subjects. 
 
Exercise dyspnea in 
patients with COPD 
 
Stendardi, Binazzi, 
and Scano  
 
 
 
 
 
 
Review of exercise 
dyspnea in COPD 
None Despite the unaltered ventilatory 
equivalents for carbon dioxide, pulmonary 
rehabilitation produces less Borg per unit 
of change in ventilation; which results in 
improved mechanical efficiency. To 
summarize the effects of pulmonary 
rehabilitation has on gas exchange 
exercise training reduces dyspnea by 
reducing the inspiratory effort, end-
expiratory-lung-volume and respiratory 
rate. The end effect is a reduction in the 
respiratory effect to concurrent volume 
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Literature Review of the Benefits of PR for Obstructive Respiratory Diseases 
Author/title Study Aim Sample Results Implications for practice, research, theory 
Severe exercise-
induced hypoxemia. 
 
Garvey, Tiep, Barnett, 
Carter, Hart and 
Casaburi 
 
 
 
 
Review of severe 
exercise-induced 
hypoxemia 
None Recommended oxygen saturation should be the 
center of monitoring of a pulmonary 
rehabilitation program to improve hypoxia 
experienced by recipients suffering from COPD.  
Contrary to other studies which have 
recommended high intensity workouts, Garvey et 
al are recommending low intensity exercise in 
initial states of exercise, until clinical baselines 
are defined such as dyspnea levels, oxygen 
saturation, and heart rate. 
 
Pulmonary rehabilitation 
improves heart rate varia
bility at peak exercise,ex
ercise capacity  
and health-
related quality of life in c
hronic obstructivepulmo
nary disease. 
 
Cheng, Wu, Yang, 
Huang C., Huang H., 
Chu W., and Lan C  
 
 
 
 
 
 
 
Evaluate the effects 
pulmonary 
rehabilitation has on 
the impaired cardiac 
autonomic 
modulation in 
recipients with 
COPD which causes 
depressed heart rate 
variability. 
Sixty-four patients 
with COPD 
participated in a 12-
week, 2 sessions-per-
week, hospital-based 
PR program. 
Baseline and post-PR 
status were evaluated 
by spirometry, 
HRV, health-
related quality of life 
(HRQL, St. George's 
Respiratory 
Questionnaire, 
SGRQ), 
cardiopulmonary 
exercise test, 
respiratory muscle 
strength, and dyspnea 
Borg's scale. 
 
 Despite the unaltered ventilatory equivalents for 
carbon dioxide, pulmonary rehabilitation 
produces less Borg per unit of change in 
ventilation; which results in improved 
mechanical efficiency. To summarize the effects 
of pulmonary rehabilitation has on gas exchange 
exercise training reduces dyspnea by reducing 
the inspiratory effort, end-expiratory-lung-
volume and respiratory rate. The end effect is a 
reduction in the respiratory effect to concurrent 
volume 
The results of the study showed a significant improvement in 
autonomic modulation at peak exercise after pulmonary 
rehabilitation. The improvements in autonomic modulation not only 
occurred at peak exercise but also during periods of rest. The 
authors contribute the reason for the marked improvement in 
autonomic modulation is related to exercise training re-establishes 
exercise tolerance, decreases ischemic metabolites during exercise 
and further reduces sympathetic activity. In conclusion pulmonary 
rehabilitation decreased parasympathetic activity and increased 
sympathetic activity, improved the balance between 
parasympathetic and sympathetic activities, and improved heart rate 
variability. 
Impact of resistance 
training in chronic 
obstructive pulmonary 
disease patients during 
periods of acute 
exacerbation 
 
Borges, RC and 
Carvalho, CR  
To evaluate the 
effects of whole-
body resistance 
training on exercise 
capacity, health-
related quality of 
life (HRQOL), and 
muscle strength in 
patients hospitalized 
for exacerbation of 
chronic obstructive 
pulmonary disease 
 
 
 
Patients (N=46) were 
randomized to either 
a control group (CG) 
or training group 
(TG), and 29 patients 
completed the study 
Increases muscle strength and improves exercise 
capacity in recipients with COPD. The 
researchers believe the peak improvement in 
muscle strength was directly related to an 
improvement in neurologic adaptation.  
The researchers concluded that pulmonary rehabilitation can be a 
useful intervention to reduce or prevent decreases in muscle 
strength during hospitalizations 
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Literature Review of the Benefits of PR for Obstructive Respiratory Diseases 
Predictors of benefit 
following pulmonary re
habilitation for interstit
iallung disease 
 
Holland et al 
evaluate the impact 
of pulmonary 
rehabilitation on the 
severity of ILD 
prospective study of 
44 subjects with ILD 
The results of the study showed improvement in 
functional exercise capacity for people with IPF. 
The differences in the improvement in the 
functional exercise capacity of individuals with 
IPF compared with individuals with COPD is the 
improvements were related to markers of disease 
severity and prognosis. The highest peak of 
improvements were seen when the disease was at 
its mildest. ILD is one of the least commonly 
referred disease processes for pulmonary 
rehabilitation because many physicians feel the 
benefits are unproven. 
The results of this study prove the benefits of pulmonary 
rehabilitation for IPF are greater when delivered early in the course 
of the disease, but regardless of disease severity individuals with 
ILD are still likely to achieve sustained improvements in dyspnea 
and quality of life 
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   Literature Review of the Benefits of PR for Restrictive Lung Diseases 
Author/title Study Aim Sample Results Implications for practice, research, theory 
Respiratory muscle 
function in patients 
with cystic fibrosis. 
 
Dassios, Katelri 
Doudounakis and 
Dimitriou  
 
 
 
the beneficial role of 
exercise in maintain 
their health and to see 
the effects of regular 
exercise on the 
respiratory muscle 
function indices 
44 cystic fibrosis 
recipients 
The results of the study indicate that exercise 
training is beneficial for individuals with cystic 
fibrosis. Exercise training leads to strengthening of 
the respiratory muscles which will aid in 
maintaining ventilatory balance. 
The results of the study indicate that exercise training is 
beneficial for individuals with cystic fibrosis. Exercise 
training leads to strengthening of the respiratory muscles 
which will aid in maintaining ventilatory balance 
Exercise programme 
in recipients with 
cystic fibrosis: A 
randomized controlled 
trial 
 
Rovedder et al. 
 
 
randomized 
controlled study of 
46 transplant 
recipients with a pre-
transplant diagnosis 
of COPD 
demonstrated 
participation in 
resistance training as 
part of pulmonary 
rehabilitation 
program 
clinical trial of adults 
with CF, who 
participated in home-
based pulmonary 
rehabilitation program 
with aerobic training 
and muscle strength 
training 
did not show any positive effects in muscle strength 
of the lower limbs or aerobic condition. Rovedder 
et al. (2014) explain the lack of gain in muscle 
strength as a result of the difference in the size of 
the muscle groups exercised. Another reason for no 
effect in muscle strength was the study time may 
have been too short for effects of training to be 
seen. To explain no improvement in the aerobic 
condition of recipients who participated in 
pulmonary rehabilitation, Rovedder et al (2014) 
contributed this to the recipients’ combination of 
previous illness and lack of physical activity which 
would contribute to low tolerance to exercise and 
limited gain in fitness 
The results of this study are an outlier as many of the present 
CF studies have shown several benefits of pulmonary 
rehabilitation including an increase in muscle mass, muscle 
strength, body weight, and a decrease in residual volume 
which attributes to great flexibility and thoracic mobility 
Safety and efficacy of 
 exercise training in 
various forms of 
 Pulmonary 
hypertension. 
 
Grunig et al., 2012 
 
 
 
The efficacy and 
safety of respiratory 
and exercise training 
in recipients 
diagnosed with 
pulmonary 
hypertension 
183 patients with PH 
(pulmonary arterialhype
rtension (PAH), chronic 
thromboembolic PH 
and PH due to 
respiratory or left heart 
diseases 
received exercise trainin
g in hospital for 3 
weeks and continued at 
home.  
The results of the study showed that exercise 
training can improve the quality of life, peak 
oxygen consumption, exercise capacity, oxygen 
pulse even in recipients who are classified in WHO 
functional class IV (individuals who are unable to 
carry out any physical activity without symptoms; 
these recipients typically display symptoms of 
fatigue even at rest and discomfort is increased 
with activity).  However, PH is different than other 
non-COPD diseases in response to pulmonary 
rehabilitation. The effects of exercise training is 
independent on the etiology of PH 
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Literature Review of the  Benefits of Pulmonary Rehabilitation Prior to Lung Transplant 
Author/title Study Aim Sample Results Implications for practice, research, 
theory 
Pulmonary rehabilitation in  
lung transplant candidates 
 
Li, Mathur, Chowdury, 
Helen, and Singer 
randomized controlled 
study of 46 transplant 
recipients with a pre-
transplant diagnosis of 
COPD demonstrated 
participation in 
resistance training as 
part of pulmonary 
rehabilitation program 
a retrospective cohort 
study of recipients 18 
years of age and older 
who have received a 
single, double, or 
heart-lung transplant 
between January 2004 
and June 2009 at 
Toronto General. The 
recipients had to have 
pre-transplant exercise 
data available. The 
recipients participated 
in pulmonary 
rehabilitation during 
the entire waiting 
period three times a 
week for 1.5 to 2 hour 
sessions. 
The results of the study did not show an improvement in the 
recipients 6MWD after participating in pulmonary rehabilitation, 
but the recipients were able to maintain pre transplant 6MWD. Li 
et al. results revealed the greater the final 6MWD prior to 
transplant was associated with a shorter hospital length of stay.   
 
 
Effects of pulmonary 
rehabilitation in 
bronchiectasis: A 
retrospective study 
 
Ong, Lee, Hill, Holland & 
Denehy 
evaluate the impact of 
pulmonary 
rehabilitation on the 
severity of ILD 
111 recipients, 
diagnosed with 
bronchiectasis who 
participated in a 
retrospectively study, 
demonstrated 
individuals with 
bronchiectasis achieve 
improvements in 
exercise capacity and 
quality of life after 
participating in a 6 
week to 8 week 
outpatient pulmonary 
program 
The effects of pulmonary rehabilitation were able to be 
maintained for 12 months post pulmonary rehabilitation. The 
results of this study also provide support that individuals with 
bronchiectasis do not have a significantly different response to 
pulmonary rehabilitation than recipients with COPD, which is 
useful information for physicians who have concerns of referring 
recipients with bronchiectasis for pulmonary rehabilitation 
 
A pilot study of pulmonary 
rehabilitation and chest 
physiotherapy versus chest 
physiotherapy alone 
in bronchiectasis 
 
 
Mandal et al. 
The aim of our study 
was to assess the 
efficacy of pulmonary 
rehabilitation in 
addition to regular 
chest physiotherapy in 
non cystic 
fibrosis bronchiectasis. 
Thirty patients with 
clinically 
significant bronchiecta
sis and limited 
exercise tolerance 
were randomized into 
either the control or 
intervention group. 
a pilot comparison study in bronchiectasis recipients who 
received chest physiotherapy versus bronchiectasis recipients 
who received chest physiotherapy (CP) and pulmonary 
rehabilitation found adding pulmonary rehabilitation to CP led to 
significant improvements in exercise capacity compared to 
recipients who received CP alone 
The improvements in exercise capacity 
was maintained for 12 weeks after the 
intervention ended 
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6-minute Walk Distance (6MWD) as Determinant of Survival in Transplant Candidates 
 Exercise testing has become a convenient method of evaluating respiratory function; the 
six-minute walk distance is one way to measure this. The six-minute walk has proven to be 
reproducible and is tolerated by recipients with various disease severities. The six-minute walk 
test evaluates the distance a person can walk on a flat, rigid surface in six-minutes; the purpose 
of the test is to determine exercise tolerance and oxygen saturation during submaximal exercise 
(Morales-Blanhir, 2011). 
 A study population of 376 recipients with diverse native diseases listed for lung 
transplantation who were prospectively followed from the time of listing onward. The results of 
the study found a relationship between baseline 6MWD and patient mortality (after variable 
adjustment). The results indicated that in a 28 month follow up period for every 500 foot 
increments in baseline 6MWD there was greater than 50% reduction in mortality-this trend was 
seen across all diseases categories and through transplantation. The researchers found that the 
baseline 6MWD is predictive of survival regardless of transplant status (Martinu, 2008). 
 In another retrospective cohort study, 51 recipients who were diagnosed with ILD 
analyzed if the 6MWD is associated with survival in recipients with ILD referred for lung 
transplantation. The results of the study did show that oxygen saturation and 6MWD are 
associated with the risks of death in recipients with IlD who were evaluated for lung 
transplantation. Oxygen desaturation with exercise is one of the common respiratory issues of 
ILD; researchers of the study found that lower oxygen saturation during exercise or recovery was 
associated with an increased risk of death. To conclude the results of this study found excellent 
sensitivity and specificity of oxygen saturation <95% with unloaded exercise and 6MWD < 
350m for prediction of death on the list for recipients with ILD for a patient with oxygen 
saturation of <95% there was a 75% chance of dying on the list (Kawut, 2005). 
 For lung transplant candidates the 6MWD has shown high sensitivity as a predictor of 
mortality. Among recipients on the waiting list for transplantation on a 6MWD of less than 300m 
was associated with much earlier mortality. The 6MWD is a useful tool that represents an 
accurate and efficient method of quantifying exercise tolerance.  
 Kenn et al. (2014) conducted a retrospective clinical pre-analysis and post-analysis of 
lung transplant candidates in pulmonary rehab. The aim of their study was to see how effective 
PR was in not only in recipients with COPD but in recipients with other lung diseases waiting for 
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transplant. The results of their study showed short-term comprehensive PR can significantly 
improve exercise capacity. The data of this study showed two other positive effects of PR: 1) 
candidates with greater exercise capacity prior to lung transplant showed favorable post-
transplant outcomes, 2) candidates, both with COPD and restrictive lung diseases, showed an 
increase in 6MWD. These two important positive effects support that PR is beneficial for 
candidates pre-transplant and will results in better post-transplant outcomes for the patient. 
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CHAPTER III 
 Methods 
Introduction 
 The study contained several variables related to post-transplant outcomes. In order to 
appropriately consider all factors believed to affect transplant recipient’s post-transplant hospital 
outcomes and to determine the variables to be used in the study, we conducted through extensive 
research literature and looked for variables that clearly demonstrated risk or protective properties 
that could potential affect the hospital outcomes of transplant recipients. Institutional Review 
Boards at Georgia State University and Emory University approved the study as exempted 
research. 
Study Design and Sample 
The study is a non-probability sample of lung transplant recipients who underwent 
surgery from February 8, 2007 to July 8, 2014. The information from the data set was obtained 
from a secondary data source, the data warehouse at Emory University Transplant Center. 
Subjects were recipients with diverse end-stage lung disease processes.  
During this period the total number of recipients was 214; seven transplant recipients 
were excluded due to death immediately after transplant while in the hospital. Thus, the sample 
size for this study is 207 transplant recipients with a 5.0% margin of error and a 95% confidence 
interval. 
Measures 
 The instruments used to collect data on transplant recipients was the data warehouse at 
Emory University Hospital and chart abstraction. Pre-transplant and post-transplant coordinators 
and other healthcare disciplines update and enter the transplant recipient’s data in the data 
warehouse during the pre and post-transplant phase of care. Chart abstraction was used to 
collected limited data information on the transplant recipients’ participation in preoperative 
pulmonary rehabilitation and six-minute walk distance.  
Data Analysis Overview 
Independent Variables 
  Three independent variables were tested in this study: 1) pulmonary rehabilitation, 2) 
six-minute walk distance, and 3) total number of preoperative behaviors. 
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Preoperative Pulmonary Rehabilitation 
 Preoperative pulmonary rehabilitation was defined as a dichotomous variable:  
participation and no participation. Participation in pulmonary rehabilitation was based on the 
guidelines of the American Association of Cardiovascular and Pulmonary Rehabilitation 
(AACVPR) [American Association of Cardiovascular…2004]. Participation in preoperative 
pulmonary rehabilitation including participating in one of the three following levels of 
rehabilitation:  
• Inpatient pulmonary rehabilitation must have: a) attended 3-5 preoperative pulmonary 
sessions a week, b) for 30 to 90 minutes a session and c) for at least 4 weeks, and d) 
within 6 months of transplant. 
• Transplant recipients who participated in home pulmonary rehabilitation must have 
attended one inpatient session (which will provide home pulmonary instructions tailored 
to disease severity and patient tolerance) and  a) work-out 3-5 sessions a week, b) for 30 
to 90 minutes, c) for at least 4 weeks, and d) within 6 months of transplant. 
• Transplant recipients with decline in pulmonary function must have participated in 
preoperative pulmonary rehabilitation interval training: a) 10-30 minutes sessions with 
breaks as needed, b) 5 to 7 days a week, c) for at least 4 weeks and d) within 6 months of 
transplant. 
 Inpatient and home preoperative rehabilitation must have been performed on a stationary 
bike where resistance can be changed and distance measured, treadmill or surface track. Upper 
arm exercises should have been performed on an arm ergometry, with light weights or 
Therabands. In order to decrease a possible bias towards the null, preoperative pulmonary 
rehabilitation inclusion was not limited to recipients who completed pulmonary programs.  
Recipients with any participation in pulmonary rehabilitation were considered as engaging in 
preoperative pulmonary rehabilitation. Lung transplant recipients who did not engage in 
preoperative pulmonary rehabilitation were the referent group. 
Six-Minute Walk Distance (6MWD) 
 The 6MWD is an index used to determine the transplant recipient’s ability to perform 
daily life activities. The 6MWD measures the distance a transplant candidate can walk within a 
6-minute time limit; the distance is measured in feet (ft.) or meters (m). A study by Duke 
University researchers found for every 50 meter increased in walk distance over 207 meters 
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during 6MWD there was an increase in survival. There was approximately a 1.5 greater relative 
risk of survival for lung transplant recipients who walked greater than 207 meters compared to 
those who walked less than 207 meters (Martinu, Babyak, and Palmer, 2008). Based on the 
results of the Duke University study, 6MWD was dichotomized into two categories. The first 
category was transplant recipients who walked 207 meters and more in their last preoperative 
6MWD. The second category were transplant recipients who walked less than 207 meters in their 
last preoperative 6MWD. The referent group was lung transplant recipients who walked less than 
207 meters during their last preoperative 6MWD. 
Total Number of Preoperative Behaviors 
 The remaining variable is a created by two combined variable. Preoperative pulmonary 
rehabilitation and 6MWD to create a new variable. The variable is an exploratory variable with 
three categorical levels. The first level is no participation in preoperative pulmonary 
rehabilitation and 6MWD less than 207 meters. The second level is participation in preoperative 
pulmonary rehabilitation or 6MWD greater than or equal to 207 meters. The third level is 
participation in preoperative pulmonary rehabilitation and greater than or equal to 207 meters. 
Dependent Variables 
 Transplant recipients readmitted in the first 90 days post-transplant were defined as a 
“yes”.  Recipients not admitted in the first 90 days post-transplant were defined as a “no”. The 
number of readmissions was dichotomized to two levels: less than two readmissions or greater 
than two admissions in the first 90 days post-transplant. Dichotomization of this variable was 
based on a study conducted by Vigneswaran et al. (2010). The study results showed early 
admissions in the first 90 days post-transplant are an early predictor of recipient survival 
following isolated lung transplantation. The results indicated the 90-day conditional survival at 
one, three, and five years for those patients readmitted within 90 days were 76%, 59%, and 52%, 
respectively. For patients not readmitted the values were respectively 93%, 80%, and 76%. 
The variable length of stay was dichotomized as 12 days and less and greater than 12 
days based on clinical knowledge as transplant practitioner and univariate statistics from the 
current data. The results of PROC UNIVARIATE for the length of stay the mode was 14 days 
and the 25% quantile was 12 days.  
 Further support for this dichotomization is based on clinical observations where the 
average length of stay for transplant recipients is 7-14 days. The goal of the transplant team is to 
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discharge safely and efficiently the new transplant recipients once they are stable to decrease the 
risk of hospital acquired infection. Transplant recipients are typically discharged home 14 days 
post-transplant. Further support for this dichotomization is based on clinical observations where 
the average length of stay for transplant recipients is 7-14 days.  
 Other transplant recipients’ characteristics were gender (male/female), racial ethnicity 
(Caucasian, African American, other), age (less than 20, 20-44, 45-54, 55 and older), and pre-
transplant diagnosis body mass index (underweight, normal, overweight, obese). Transplant 
recipients’ clinical data were pre-transplant diagnosis (chronic obstructive pulmonary disease 
[COPD]), idiopathic pulmonary fibrosis [IPF], sarcoidosis, cystic fibrosis, other end-stage lung 
diseases), and lung laterality (single or double lung). 
  All analyses were conducted using Statistical Analysis System (SAS) 9.3 software. SAS 
survey procedures were employed to account for complex study design. Descriptive statistics 
was obtained, to summarize, the distribution of study variables. The chi-square (X2) statistic was 
used to compare the differences in the distribution of participation of recipients who participated 
in preoperative pulmonary rehabilitation within each recipient characteristic. The column percent 
used in the two-way table was used to analyze the differences in within each category. For 
example to analyze males who participated in preoperative pulmonary rehabilitation compared to 
males who did not participate in preoperative pulmonary rehabilitation.  
 Logistic regression calculates the probability or success over the probability of failure, 
the results of the analysis are in the form of an odd ratio. The dependent variable in the logistic 
regression is usually dichotomous. The independent or predictor variables in the logistic 
regression can take any form. Logistic regression makes no assumption about the distribution of 
the independent variables. The independent variables do not have to be normally distributed, 
linearly related or of equal variance within each group. The goal of logistic regression is to 
predict the category of outcome for individual cases using the most parsimonious model 
correctly. 
 Logistic regression was used to examine the association between dependent variables, 
6MWD and preoperative pulmonary rehabilitation and independent variables. For all statistical 
analyses, a level of α = 0.05 was used for significance testing. 
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CHAPTER IV 
 Results 
Sample Demographics 
The final analytic data consisted of 207 lung transplant recipients, 128 recipients who 
participated in preoperative pulmonary rehabilitation and 79 who did not participate in 
preoperative pulmonary rehabilitation.  
The recipients ranged in age from 16 to 73 years with a mean age 55.10 years 
(SD=11.91) and a mean BMI of 25 (SD=4.48) for the study population. The largest transplant 
recipient age group for both men and women were adults age 55 and older. As shown in Table 
4.1 adults age 55 and older were more likely to participate in preoperative pulmonary 
rehabilitation compared other age groups (p<0.05).  
A stratified analysis of Africans Americans participation in preoperative pulmonary 
rehabilitation, age, and gender was performed. African American males who were 55 years of 
age and older were 1.54 more times likely not to participate in preoperative pulmonary 
rehabilitation compared to African American females (p<0.05).  
Cystic Fibrosis and other (BOOP, Apha-1) pre-transplant diagnosis have the highest 
percent of recipients who did not participate in preoperative pulmonary rehabilitation. A 
stratified analysis of preoperative pulmonary rehabilitation and gender while controlling for pre-
transplant diagnosis was completed. The results of the analysis revealed females diagnosed with 
cystic fibrosis were 1.12 times more likely not to participate in pulmonary rehabilitation 
compared to males diagnosed with cystic fibrosis.  However, males with other pre-transplant 
diagnoses were 1.32 times more likely not to participate in preoperative pulmonary rehabilitation 
compared to females diagnosed with other pre-transplant diagnoses. 
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Table 4.1 Transplant Recipients Pre-Transplant Demographics Characteristics and Clinical Data 
 Pre-Op Rehab No Pre-Op Rehab P-value 
 
N = 128 N= 79 
 
Gender   0.0550 
  Male 56.25 69.62  
  Female 43.75 30.38  
Ethnic Race   0.1573 
  Caucasian 81.25 70.89  
  African American 15.63 26.58  
  Other 3.13 2.53  
Age   0.0037 
  Less than 20 0 3.80  
  20-44 10.94 20.25  
  45-54 11.72 20.25  
  55-older 77.34 55.70  
Pre transplant Diagnosis   0.0003 
   COPD 36.72 20.25  
   IPF 43.75 44.30  
   Sarcoidosis 6.25 2.53  
   Bronchiectasis 3.91 0.00  
   Cystic Fibrosis 3.13 12.66  
   Other 6.25 20.25  
Pre-transplant BMI   0.5655 
   Underweight 6.25 8.86  
   Normal 38.28 41.77  
   Overweight 42.19 41.77  
   Obese 13.28 7.59  
6MWD   0.0240 
   Less than 207 meters 17.32 31.08  
  207 meters and more 82.68 68.92  
Laterality   0.6548 
  Single lung transplant 24.22 21.52  
  Bilateral lung transplant 75.78 78.48  
Smoking History   0.1081 
     Former Smoker  54.43 65.63  
     Never Smoked 45.57 34.38  
+ Numeric values in table are column percentages from Chi-square data analysis 
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Table 4.2 Descriptive Summary Statistics for Pre-Transplant Recipients 
 
 
 
 
 
Bivariate Logistic Regression 
Research Question 1: Do lung transplant recipients who engaged in preoperative 
pulmonary rehabilitation differ on post-operative hospital readmissions compared to those who 
did not engage in preoperative pulmonary rehabilitation? 
H01: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have 
an equal odds of being readmitted post 90 days compared to lung transplant recipients who did 
not engage in preoperative pulmonary rehabilitation. 
Table 4.3 shows regressions coefficients with an odds ratio and significance level at 
α=0.05. The results indicates that the odds of being admitted post 90 days is greater for those 
who engage in preoperative rehabilitation compared to those who did not engage in preoperative 
pulmonary rehabilitation. Transplant recipients who engaged in preoperative pulmonary 
rehabilitation were 1.77 times more likely to be readmitted within the first 90 days compared to 
transplant recipients who did not engage in preoperative pulmonary rehabilitation. The null 
hypothesis was rejected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables Count Mean Standard 
Deviation 
Age 207 55.09662 11.9127222 
Pre-transplant BMI 207 25.0 4.47693294 
Six-minute Walk 
Distance 
201 271.1940 90.14725527 
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Table 4.3 Summary of Logistic Regressions Analysis of the Association of the Effect of 
Preoperative Pulmonary Rehabilitation on Transplant Recipients Readmissions in the First 
90 Days Post-transplant  
 
 Readmission in First 90 Days Post Transplant 
Parameter Estimate Odds Ratio P-value 
Intercept -0.0253   
Did not participate in 
preoperative 
pulmonary 
rehabilitation 
 1.00 (Referent group)  
Participated in 
preoperative 
pulmonary 
rehabilitation 
 1.77+ 0.0497 
H02: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have 
an equal odds of having < 2 readmissions when compared to lung transplant recipients who did 
not engage in preoperative pulmonary rehabilitation. 
Estimates in Table 4.4,indicate that there is no difference in lung transplant recipients who 
engaged in preoperative pulmonary rehabilitation when compared to lung transplant recipients 
who did not engage in preoperative pulmonary rehabilitation in odds of having <2 admissions. 
Therefore we fail to reject the null hypothesis. 
Table 4.4 Summary of Logistic Regressions Analysis of the Association of the Effect of 
Preoperative Pulmonary Rehabilitation on the Number of Post-transplant Readmissions 
    
Number of Post-Transplant Readmissions 
Parameter Estimate Odds Ratio P-value 
Intercept 1.2204   
Did not participate in 
preoperative 
pulmonary 
rehabilitation 
 1.00 (Referent group)  
Participated in 
preoperative 
pulmonary 
rehabilitation 
 0.65 0.1893 
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Research Question 2: Do lung transplant recipients who engaged in 6MWD differ on hospital 
length of stay post-surgery compared to those who did not engage in a 6MWD? 
H01: Lung transplant recipients who engaged in 6MWD will have an equal odds of having ≤ 12 
day stay compared to lung transplant recipients who did not engage in 6MWD.  
For research question two we reject the null hypothesis that transplant recipients who engaged in 
6MWD of 207 meters or more do not differ from transplant recipients who walked less than 207 
meters on hospital length of stay post-surgery. Transplant recipients who engaged in a 6MWD of 
207 meters or more were 4.99 times more likely to be discharged from the hospital in less than 
12 days post-transplant surgery compared to transplant recipients with a 6MWD of less than 207 
meters. 
 
Table 4.5 Summary of Logistic Regression Analysis of the Association of Effect of 
Transplant Recipients last Pre-Transplant Six-minute Walk Distance on Length of Stay in 
the Hospital after Transplant Surgery  
 
Length of Stay in Hospital After Transplant Surgery 
Parameter Estimate Odds Ratio P-value 
Intercept -2.6391   
Walked less than 207 
meters 
  1.00  
(Referent group) 
 
Walked 207 meters 
and more 
 4.99+ 0.0101 
+ 6 observations were 
deleted due to missing values 
for the response 
   
 
Exploratory Research Question 3: Do lung transplant recipients who did not engage in both 
preoperative pulmonary rehabilitation and SMWD differ on hospital admissions from those who 
engaged in at least one or both of the preoperative behaviors?  
There were three outcomes examined in this research question. The first outcome 
examined transplant recipients who engaged in preoperative pulmonary rehabilitation or engaged 
in a SWMD greater than or equal to 207 meters. The second outcome examined transplant 
recipients who engaged in preoperative pulmonary rehabilitation and engaged in a SMWD was 
greater than or equal to 207 meters. The third outcome, the referent group, examined transplant 
recipients who did not engage in preoperative pulmonary rehabilitation and engaged in SMWD 
less than 207 meters.  
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Table 4.6, we reject the null hypothesis. Lung transplant recipients who did not engage in 
both preoperative pulmonary rehabilitation and 6MWD do not differ on hospital admissions from 
those who engaged in at least one or both of the preoperative behaviors.  
Transplant recipients who participated in preoperative pulmonary rehabilitation or whose 
6MWD was greater than or equal to 207 meters have 3.10 times of odds of being readmitted in 
the first 90 days post-transplant compared to transplant recipients who did not participate in 
preoperative rehabilitation and SMWD less than 207 meters. 
Transplant recipients who participated in both preoperative pulmonary rehabilitation and 
whose 6MWD was greater than or equal to 207 meters have 3.72 times the odds of being 
readmitted in the first 90 days post-transplant compared to transplant recipients who did not 
participate in preoperative rehabilitation and SMWD less than 2-7 meters. 
 
Table 4.6 Summary of Logistic Regressions Analysis of the Association of the Effect of 
Variable Total Number of Preoperative Behaviors Rehabilitation on Transplant Recipients 
Readmissions in the First 90 Days Post-transplant  
 
Readmission in First 90 Days Post-Transplant 
Parameter Estimate Odds Ratio P-value 
Intercept -0.6286   
Did not participation 
in preoperative 
pulmonary 
rehabilitation and 
SWMD less than 207 
meters 
 1.00 
Referent group 
 
Participated in 
preoperative 
pulmonary 
rehabilitation or 
SMWD was greater 
than or equal to 207 
meters 
 3.10 0.0159 
Participated in 
preoperative 
pulmonary 
rehabilitation and 
SMWD was greater 
than or equal to 207 
meters 
 3.72 0.0037 
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There is no difference in the number of post-transplant readmissions in the first 90 days 
post-transplant between those who participated in preoperative pulmonary rehabilitation or 
whose 6MWD was greater than or equal to 207 meters compared to those who did not participate 
in pulmonary rehabilitation and whose SMWD was less than 207 meters (Table 4.7); we fail to 
reject the null hypothesis. 
Table 4.7 we fail to reject the null hypothesis. There is no difference in the number of 
post-transplant readmissions in the first 90 days between those who participated in preoperative 
pulmonary rehabilitation and whose 6MWD was greater than or equal to 207 meters compared to 
those who did not participate in pulmonary rehabilitation and whose SMWD was less than 207 
meters. 
Table 4.7 Summary of Logistic Regressions Analysis of the Association of the Effect of 
Variable Total number of preoperative behaviors on the Number of Post-transplant 
Readmissions in the first 90 days 
Number of Post-Transplant Readmissions in First 90 Days 
Parameter Estimate Odds Ratio P-value 
Intercept 1.5581   
Did not participation 
in preoperative 
pulmonary 
rehabilitation and 
SWMD less than 207 
meters 
  1.00  
Referent group 
 
Participated in 
preoperative 
pulmonary 
rehabilitation or 
SMWD was greater 
than or equal to 207 
meters 
 0.55 0.2809 
Participated in 
preoperative 
pulmonary 
rehabilitation and 
SMWD was greater 
than or equal to 207 
meters 
 0.50 0.1916 
 
In Table 4.8, we fail to reject the null hypothesis;  there is no difference between 
recipients who participated in preoperative pulmonary rehabilitation or who 6MWD was greater 
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than or equal to 207 meters compare to transplant recipients who did not participate in 
preoperative pulmonary rehabilitation or complete a 6MWD. 
However, transplant recipients who participated in preoperative pulmonary rehabilitation 
and whose 6MWD was greater than or equal to 207 meters had 2.34 times the odd of having a 
length of stay of 12 days or less after transplant surgery, so we reject the null hypothesis. 
  
 
Table 4.8 Summary of Logistic Regression Analysis of the Association of the Variable Total 
number of preoperative behaviors on Length of Stay in the Hospital after Transplant 
Surgery 
 
Length of Stay in the Hospital  After Transplant 
Parameter Odds Ratio P-value 
Did not participation in preoperative 
pulmonary rehabilitation or complete a 
6MWD 
1.00 
Referent group 
 
Participated in preoperative pulmonary 
rehabilitation or SMWD was greater than 
or equal to 207 meters 
1.82 0.1202 
Participated in preoperative pulmonary 
rehabilitation and SMWD was greater 
than or equal to 207 meters 
2.34 0.0222 
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Chapter V 
Discussion and Conclusion 
 
The findings of the study did and did not support the study’s original research questions and 
hypotheses.  
The first research question related to the association between participation in preoperative 
pulmonary rehabilitation and readmissions in the first 90 days post-transplant yield unusual 
findings.  The results of regressions analysis showed a significant association between recipients’ 
who participated in preoperative pulmonary rehabilitation and readmission in the first 90 days 
post-transplant. 
 The second research question’s focus was on the association between preoperative 
pulmonary rehabilitation and number of hospital admissions in the first 90 days post-transplant.  
As with the results showed recipients who participated in preoperative pulmonary rehabilitation 
were more likely to have more than two hospital readmissions compared to those who did not 
participate in preoperative pulmonary rehabilitation. The results of this association were not 
statistically significant. 
 The next research question focused on recipients 6MWD and length of stay in the 
hospital. The results show an association between recipients’ who participate in preoperative 
pulmonary rehabilitation or whose 6MWD was greater than or equal to 207 meters and recipients 
who participated in pulmonary rehabilitation and whose 6MWD was greater than 207 meters 
found that there was an association of readmission in the first 90 days post-transplant. 
  The number of preoperative behaviors research questions results was a summary of all 
previous behaviors tested in other research questions. The results of this research question 
yielded unexpected results. Recipients who participated in preoperative pulmonary rehabilitation 
and/or had a 6MWD greater than or equal to 207 meters were more likely to be admitted in the 
first 90 days post-transplant.  
Preoperative pulmonary rehabilitation is believed to be beneficial or have an almost 
“protective” effect post-transplant. Conversely, the results showed transplant recipients who 
participated in pulmonary rehabilitation and/or had a 6MWD greater than or equal to 207 meters 
were readmitted in the first 90 days. We assessed the other baseline covariates for potential 
answers to why this association may have occurred, but further analysis of the covariates did not 
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present additional findings. We do, however, have a theory and plausible explanation for the 
observed observations. 
Based on standard clinical practice and observations at Emory University, plausible 
explanations for these findings are as follows. It is possible that transplant recipients who remain 
actively engaged while waitlisted tend to be more proactive in their post-transplant care. 
Observations of these patients indicate that they are more likely to contact the transplant team 
when they have a medical concern or issue. Since the greatest risk of mortality for transplant 
recipients is the first year post-transplant, the Emory transplant team is aggressive in ensuring 
recipients are healthy and very cautious when recipients show signs of illness. When the 
proactive transplant recipient who is less than 90 days post-transplant calls with a medical 
illness, the transplant teams will more than likely admit the transplant recipient. These 
explanations are based upon experiences of the researchers and therefore to substantiate and test 
this theory. A study is needed with larger sample size to understand the results better.  
There was an association between a recipient’s 6MWD (greater than or equal to 207 
meters) and length of stay of 12 days or less. The results of  logistic regression analysis among 
recipients’ who participate in preoperative pulmonary rehabilitation or whose 6MWD greater 
than or equal to 207 meters and recipients who participated in pulmonary rehabilitation and 
whose 6MWD was greater than 207 meters found that there was an association of readmission in 
the first 90 days post-transplant. Participation in preoperative pulmonary rehabilitation and 
6MWD of greater than or equal to 207 meters was associated with a length of stay of 12 days or 
less in the hospital after transplant surgery. This finding supports the data of previous research 
studies of the importance of pulmonary rehabilitation of increasing 6MWD. This finding also 
illustrates the importance of both participation in preoperative pulmonary rehabilitation and 
6MWD on transplant recipients outcomes.    
Some results in the present study were not statistically significance, however may have 
practical significance on recipient outcomes.  Recipients who participated in preoperative 
pulmonary rehabilitation or whose 6MWD was greater than or equal to 207 meters were 1.82 
times more likely to be discharged in 12 days or less than those who did not participate in 
preoperative pulmonary rehabilitation or complete a 6MWD.  Though this finding was not 
statistically significant, it is possible that is still has relevance, and further test with larger sample 
size is needed. 
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The outcomes were assessed for potential confounding. There was an association 
between age and length of stay after transplant.  When logistic regression was used to adjust for 
confounding, the odds ratio increased from 4.99 to 5.10, and the p-value changed from 0.0101 to 
0.0093.Since the adjusted odds ratio differed from the crudes odd ratio by less than 10%, there 
was no confounding by the covariate age.  No further confounding was found between outcomes 
and other covariates. 
There are a very limited number of studies to which the findings in this study could be 
compared. Research studies on the outcomes of preoperative pulmonary rehabilitation are 
focused on the physiological outcomes mainly in non-transplant recipients. Rochester (2008) 
physiological benefits of preoperative rehabilitation in the post-transplant phase. Rochester states 
preoperative pulmonary rehabilitation will reduce minute ventilation at comparable workloads, 
restore normal or near-normal lung function and gas exchange and elimination of substantial 
ventilatory limitation to exercise. Improvement in these respiratory physiological functions may 
enable the lung transplant recipient to exercise at higher intensities and achieve greater gains in 
aerobic and exercise fitness.  Rochester also states it is not known whether preoperative 
pulmonary rehabilitation increases survival to surgery, increases a recipients’ tolerance of 
surgery, reduces post-surgical complications or improves post-surgical outcomes.  
Six-minute walk distance (6MWD) research studies aims are to assess the benefits of 
interventions on the increase or decrease in 6MWD. Other studies on 6MWD focus on 6MWD 
predicting survival or indicating transplant candidates prognosis. Martinu et al. conducted an 
extensive large prospective two-center study. The cohort for the study was patients listed for 
lung transplantation. The researchers used Cox proportional hazard model to determine the 
importance of 6MWD in predicting the candidates’ survival. The results of the study revealed a 
50% decrease in mortality for every 500 feet (152.4m) increase in 6MWD. 
 
Strengths 
 The strengths of the study are the finding of the importance of 6MWD of the hospital 
outcomes. The finding supports the importance of recipients participation in preoperative 
pulmonary rehabilitation to achieve better postsurgical outcomes.  
 
Limitations 
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The lack of associations in the number of readmissions may have been due to smaller 
sample size and insufficient power in the study design to detect differences at the p<.05 level. . 
The total sample size was only 207 transplant recipients. The male Caucasian population was the 
largest population in the study compared to females and other ethnic races.  
The referent group used in the study was not a true control group. In healthcare, it is unethical to 
withhold a treatment that may be beneficial for a patient, so the referent group used was 
transplant recipients who decided not to participate in preoperative pulmonary rehabilitation. The 
data collected on transplant recipients’ participation in preoperative pulmonary rehabilitation was 
obtained by chart abstraction. The transplant recipients’ participation in preoperative 
rehabilitation was verified by only one person. In order to decrease potential misclassification, 
the recipients’ participation in pre-operative rehabilitation should be verified by someone else.  
Six values for recipients 6MWD were missing. The values were unable to be located during chart 
abstraction. The six missing values did not affect the normality of 6MWD variable. When 
assessed for skewness, 6MWD was normal (not skewed to the left or the right). 
 
Future Study 
Studies are needed that explain the benefits of preoperative pulmonary rehabilitation on 
post-transplant outcomes. Previous research studies regarding preoperative pulmonary 
rehabilitation primarily focused on the psychological benefits of preoperative pulmonary 
rehabilitation. Research needs to be done to show the effects of pre-operative pulmonary 
rehabilitation on decreasing surgical complications, surgical outcomes, and hospital outcomes 
(i.e. time on the mechanical ventilator and number of admissions). This study could be used as a 
baseline for future studies. The next study to assess the benefits of preoperative pulmonary 
rehabilitation on post-transplant outcomes would ideally be a prospective study design. A 
prospective cohort study with a larger sample size that would occur in transplant center where 
preoperative pulmonary rehabilitation was still optional.  The researchers would follow the 
transplant recipients from the time they are listed for lung transplant until they are one year post-
transplant. The researchers would compare the hospital outcomes investigated in this study at 
three months, six months, nine months, and one year post-transplant. A study structured with 
four follow up periods would provide the transplant research community with data on the 
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importance of preoperative pulmonary rehabilitation on hospital outcomes during the first year 
post-transplant when the chance of survival is low. 
 
 
Conclusion 
 In the first year post-transplant 78% of the patients survive. There are general risk for any 
major surgery including lung transplant. There are increased risk of pulmonary postoperative 
complications for the following risk factors: upper abdominal and thoracic surgery, surgery 
greater than 3 hours, underlying chronic pulmonary disease, and history of smoking, age greater 
than 60, obesity, and poor exercise tolerance. Transplant candidates recipients have at least 5 to 7 
of the risk factors listed which puts them at a high risk for pulmonary postoperative 
complications. Based on this list of risk factors it is vital transplant recipients have an 
understanding of the importance perioperative pulmonary rehabilitation plays in their post-
transplant hospital outcomes. 
The present analysis examined the relationship between preoperative rehabilitation, 
6MWD and hospital outcomes among transplant recipients. The association between 6MWD and 
length of stay has beneficial outcomes for the recipient and healthcare. Recipients with a 6MWD 
greater than or equal to 207 meters and who participated in preoperative pulmonary 
rehabilitation had a decreased length of stay in the hospital. The average cost per day for an 
inpatient stay in the state of Georgia averages $1605 per a day. The average length of stay for 
transplant recipients averages 7 to 14 days after transplant. A transplant recipient who 
participated in pre-operative pulmonary rehabilitation and whose 6MWD was greater than or 
equal to 207 meters length of stay was less than or equal to 12 days. This averages about $3210 
less in hospital costs. This study supports previous literature on the importance of pulmonary 
rehabilitation, but also suggests the relationship between pulmonary rehabilitation and 
readmissions is complex. 
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